Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
Rahul KallaA T AdamsD BergemalmS VatnN A KennedyP RicanekJ LindstromA OcklindF HjelmN T VenthamG T HoC PetrenD RepsilberJ SöderholmMarieke J PierikM D'AmatoF GomollónC OlbjornJ JahnsenM H VatnJ HalfvarsonJ SatsangiPublished in: Journal of Crohn's & colitis (2021)
We have characterized a simple oligo-protein panel that has the potential to identify IBD from symptomatic controls and to predict future disease course. Further prospective work is required to validate our findings.